JCOGの基本情報 > 研究実績 > 大腸がんグループ

JCOGの基本情報大腸がんグループ

更新日：2017年9月3日

  1. 論文
    1. 委員会承認の治療研究
      JCOG0205
      Y Shimada, T Hamaguchi, J Mizusawa, et al.: Randomised phase III trial of adjuvant chemotherapy with oral uracil and tegafur plus leucovorin versus intravenous fluorouracil and levofolinate in patients with stage III colorectal cancer who have undergone Japanese D2/D3 lymph node dissection: Final results of JCOG0205. European Journal of Cancer. 50(13): 2231-2240, 2014.
      JCOG0212
      S Fujita, T Akasu, J Mizusawa, et al.: Postoperative morbidity and mortality after mesorectal excision with and without lateral lymph node dissection for clinical stage II or stage III lower rectal cancer (JCOG0212): results from a multicentre, randomised controlled, non-inferiority trial. Lancet Oncol. 13(6): 616-621, 2012.
      S Fujita, J Mizusawa, Y Kanemitsu, et al.: Mesorectal Excision With or Without Lateral Lymph Node Dissection for Clinical Stage II/III Lower Rectal Cancer (JCOG0212): A Multicenter, Randomized Controlled, Noninferiority Trial. Ann Surg. 266(2):201-207, 2017.
      JCOG0404
      S Kitano, M Inomata, A Sato, et al.: Randomized controlled trial to evaluate laparoscopic surgery for colorectal cancer: Japan clinical oncology group study JCOG 0404. Jpn J Clin Oncol. 35(8): 475-477, 2005.
      S Yamamoto, M Inomata, H Katayama, et al.: Short-term surgical outcomes from a randomized controlled trial to evaluate laparoscopic and open D3 dissection for stage II/III colon cancer: Japan Clinical Oncology Group study JCOG 0404. Ann Surg. 260(1): 23-30, 2014.
      S Kitano, M Inomata, J Mizusawa, et al.: Survival outcomes following laparoscopic versus open D3 dissection for stage II or III colon cancer (JCOG0404): a phase 3, randomised controlled trial. The Lancet Gastroenterology & Hepatology. 2(4): 261-268, 2017.
      JCOG0603
      Y Kanemitsu, T Kato, Y Shimizu, et al.: Colorectal Cancer Study Group (CCSG) of Japan Clinical Oncology Group. A randomized phase II/III trial comparing hepatectomy followed by mFOLFOX6 with hepatectomy alone as treatment for liver metastasis from colorectal cancer: Japan Clinical Oncology Group Study JCOG0603. Jpn J Clin Oncol. 39(6): 406-409, 2009.
      JCOG0903
      A Takashima, Y Shimada, T Hamaguchi, et al.: A Phase I/II trial of chemoradiotherapy concurrent with S-1 plus mitomycin C in patients with clinical Stage II/III squamous cell carcinoma of anal canal (JCOG0903: SMART-AC). Jpn J Clin Oncol. 41(5): 713-717, 2011.
      JCOG0910
      T Hamaguchi, Y Shimada, J Mizusawa, et al.: Capecitabine versus S-1 as adjuvant chemotherapy for patients with stage III colorectal cancer (JCOG0910): an open-label, non-inferiority, randomised, phase 3, multicentre trial. Lancet Gastroenterol Hepatol. 3(1): 47-56. 2018.
      JCOG1006
      Y Takii, Y Shimada, Y Moriya, et al.: A Randomized Controlled Trial of the Conventional Technique Versus the No-touch Isolation Technique for Primary Tumor Resection in Patients with Colorectal Cancer: Japan Clinical Oncology Group Study JCOG1006. Jpn J Clin Oncol. 44(1): 97-100, 2014.
      JCOG1107
      M Inomata, T Akagi, H Katayama, et al.: A randomized controlled trial comparing laparoscopic surgery with open surgery in palliative resection of primary tumor in incurable Stage IV colorectal cancer: Japan Clinical Oncology Group Study JCOG 1107 (ENCORE trial). Jpn J Clin Oncol. 44(11): 1123-1126, 2014.
      JCOG1310
      M Ohue, T Hamaguchi, Y Ito, et al.: A phase I trial of preoperative S-1 in combination with oxaliplatin and pelvic radiation for lower rectal cancer with T4 and lateral pelvic lymph node metastasis. Int J Clin Oncol. 20(2): 338-344, 2015.
      S Iwasa, H Souda, K Yamazaki, et al.: Safety and efficacy of adjuvant therapy with oxaliplatin, leucovorin and 5-fluorouracil after mesorectal excision with lateral pelvic lymph node dissection for stage III lower rectal cancer. Anticancer Res. 35(3): 1815-1819, 2015.
      M Ohue, S Iwasa, Y Kanemitsu, et al.: A Phase II/III randomized controlled trial comparing perioperative versus postoperative chemotherapy with mFOLFOX6 for lower rectal cancer with suspected lateral pelvic node metastasis: Japan Clinical Oncology Group Study JCOG1310 (PRECIOUS study). Jpn J Clin Oncol. 47(1): 84-87, 2016.
      JCOG1609INT
      S Evrard, R Audisio, G Poston, et al.:From a Comic Opera to Surcare an Open Letter to Whom Clinical Research in Surgery Is a Concern: Announcing the Launch of SURCARE. Ann Surg. 264(6): 911-912. No abstract available. 2016.
      K Kataoka, K Nakamura, C Caballero, et al.: Collaboration between EORTC and JCOG-how to accelerate global clinical research partnership. Jpn J Clin Oncol. 47(2): 164-169, 2017.
    2. グループ代表者管理の治療研究
      JCOG0404
      S Kitano, M Kitajima, F Konishi, et al.: A multicenter study on laparoscopic surgery for colorectal cancer in Japan. Surg Endosc. 20(9): 1348-1352, 2006.
      K Nakajima, M Inomata, T Akagi, et al.: Quality control by photo documentation for evaluation of laparoscopic and open colectomy with D3 resection for stage II/III colorectal cancer: Japan Clinical Oncology Group study JCOG 0404. Jpn J Clin Oncol. 44(9): 799-806, 2014.
      T Etoh, M Inomata, M Watanabe, et al.: Success rate of informed consent acquisition and factors influencing participation in a multicenter randomized controlled trial of laparoscopic versus open surgery for stage II/III colon cancer in Japan (JCOG0404). Asian J Endosc Surg. 8(4): 419-423, 2015.
      JCOG0603
      T Kato, K Yasui, T Hirai, et al.: Therapeutic results for hepatic metastasis of colorectal cancer with special reference to effectiveness of hepatectomy: analysis for prognostic factors for 763 cases recorded at 18 institutions. Dis Colon Rectum. 46 Suppl: S22-S31, 2003.
      T Kato, K Yasui, Y Kanemitsu, et al.: Staging and indications for hepatectomy in hepatic metastases of colorectal cancer. Nihon Geka Gakkai zasshi. 107(3): 104-108, 2006.
      K Kato, Y Inaba, Y Tsuji, et al.: A multicenter phase-II study of 5-FU, leucovorin and oxaliplatin (FOLFOX6) in patients with pretreated metastatic colorectal cancer. Jpn J Clin Oncol. 41(1): 63-68, 2011.
      JCOG0903
      A Takashima, Y Shimada, T Hamaguchi, et al.: Current therapeutic strategies for anal squamous cell carcinoma in Japan. Int J Clin Oncol. 14(5): 416-420, 2009.
    3. 附随研究等
      JCOG0205/0910
      T Watanabe, M Itabashi, Y Shimada, et al.: Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2010 for the treatment of colorectal cancer. Int J Clin Oncol. 17(1): 1-29, 2012.
      T Watanabe, M Itabashi, Y Shimada, et al.: Japanese Society for Cancer of the Colon and Rectum (JSCCR) Guidelines 2014 for treatment of colorectal cancer. Int J Clin Oncol. 20(2): 207-39, 2015.
      JCOG0212
      S Saito, S Fujita, J Mizusawa, et al.: Male sexual dysfunction after rectal cancer surgery: Results of a randomized trial comparing mesorectal excision with and without lateral lymph node dissection for patients with lower rectal cancer: Japan Clinical Oncology Group Study JCOG0212. Eur J Surg Oncol. 42(12): 1851-1858, 2016.
      M Ito, A Kobayashi, S Fujita, et al.: Urinary dysfunction after rectal cancer surgery: Results from a randomized trial comparing mesorectal excision with and without lateral lymph node dissection for clinical stage II or III lower rectal cancer (Japan Clinical Oncology Group Study, JCOG0212). Eur J Surg Oncol. 44(4): 463-468, 2018.
      JCOG0603
      安井健三、清水泰博、平井孝、他:【大腸癌治療の進歩】大腸癌肝転移の外科治療-多施設における根治的肝切除例の検討. 癌と化学療法. 31(5): 690-694, 2004．
      安井健三、清水泰博、平井孝、他:【転移性肝癌　どこまでchallengeすべきか】大腸癌肝転移の生物学的特性-大腸癌肝転移の腫瘍辺縁形態と予後. 外科. 66(13): 1610-1614, 2004．
      Y Shimizu, K Yasui, T Sano, et al.: Treatment strategy for synchronous metastases of colorectal cancer is hepatic resection after an observation interval appropriate?. Langenbecks Arch Surg. 392(5): 535-538, 2007.
      Y Shimizu, K Yasui, T Sano, et al.: Validity of observation interval for synchronous hepatic metastases of colorectal cancer: changes in hepatic and extrahepatic metastatic foci. Langenbecks Arch Surg 393(2): 181-184, 2008.
      Y Kanemitsu, T Kato: Prognostic models for predicting death after hepatectomy in individuals with hepatic metastases from colorectal cancer. World J Surg. 32(6): 1097-1107, 2008.
      塚本 俊輔、大城 泰平、坂本 良平、他:【大腸癌肝転移の治療戦略-切除の適応とタイミング】 大腸癌肝転移に対する肝切除後の肝再発に対する治療戦略. 癌の臨床.60(5):485-491, 2014.
      JCOG1007
      K Shitara, K Matsuo, C Kondo, et al.: Prolonged Survival of Patients with Metastatic Colorectal Cancer following First-Line Oxaliplatin-Based Chemotherapy with Molecular Targeting Agents and Curative Surgery. Oncology. 81(3-4): 167-174, 2011.
      D Shida, T Hamaguchi, H Ochiai, et al.: Prognostic Impact of Palliative Primary Tumor Resection for Unresectable Stage 4 Colorectal Cancer: Using a Propensity Score Analysis. Ann Surg Oncol. 23(11): 3602-3608, 2016.
      JCOG1018
      長島文夫、濱口哲弥:高齢者大腸癌の臨床的問題と化学療法の実際. 消化器の臨床. 17(4): 350-355, 2014.
      長島文夫、濱口哲弥、古瀬純司: JCOG高齢者研究小委員会の活動と高齢大腸癌を対象とした臨床研究について. 癌と化学療. 42(1): 16-20, 2015.
      JCOG1107
      T Akagi, M Inomata, S Kitano, et al.: Multicenter study of short- and long-term outcomes of laparoscopic palliative resection for incurable, symptomatic stage IV colorectal cancer in Japan. J Gastrointest Surg. 17(4): 776-783, 2013.
    4. 総説・解説
      JCOG0205/0910
      濱口哲弥:【最新の大腸癌補助化学療法】大腸がんの術後補助療法(Stage III）国内外臨床試験成績と標準治療. 大腸癌FRONTIER. 3(1): 20-23, 2010.
      島田安博、濱口哲弥:【大腸癌治療ガイドラインのエビデンスと解説】高齢者に対する術後補助療法「高齢者における5-FU-based chemotherapy有用性」「カペシタビン療法」「オキサリプラチン併用療法」.ガイドラインサポートハンドブック 大腸癌.杉原健一 編. 医薬ジャーナル社. 129-132, 2010.
      島田安博、濱口哲弥:【大腸癌治療ガイドラインのエビデンスと解説】術後補助化学療法「5-FU/LVからFOLFOXまで」「分子標的治療薬を用いた補助療法」. ガイドラインサポートハンドブック 大腸癌．杉原健一 編. 医薬ジャーナル社. 112-119, 2010.
      JCOG0212
      藤田伸:【直腸癌治療の新知見】JCOG0212(臨床病期II・IIIの下部直腸がんに対する側方リンパ節郭清術の意義に関するランダム化比較試験). 大腸癌Frontier. 2(3): 217-220, 2009.
      森谷冝皓、赤須孝之、藤田伸、他:下部直腸癌側方リンパ節転移の治療-JCOG0212からJCOGXXへ．日本外科学会雑誌. 112(5): 325-329, 2011.
      藤田伸:直腸癌(Rb, T3N0）に対してどのような治療を選択する？ 側方郭清の立場から.消化器外科. 40: 1825-1836, 2017.
      JCOG0404
      猪股雅史、他:進行結腸癌に対する腹腔鏡下手術－厚生労働省班研究に基づく本邦の現況－. 日本内視鏡外科学会雑誌. 13(1): 47-53, 2009．
      M Inomata, K Yasuda, S Kitano, et al.: Clinical evidences of laparoscopic versus open surgery for colorectal cancer. Jpn J Clin Oncol. 38(8): 471-477, 2009.
      JCOG0603
      平井孝、加藤知行、金光幸秀:大腸癌肝転移に関する研究-大腸癌の肝転移に対する外科治療. 大腸疾患NOW. 89-104, 2004.
      加藤知行、平井孝、金光幸秀、他:【大腸疾患の外科　最新の諸問題】大腸癌肝転移・肺転移に対する治療方針　最近の諸問. 外科. 68(9): 1058-1066, 2006.
      加藤知行、平井孝、清水康博、他:【Stage IV大腸癌と診断したらどうするか】肝転移を伴うStage IV大腸癌の治療方針. 外科治療. 96(6): 984-991, 2007.平井孝、加藤知行、金光幸秀:【大腸癌治療ガイドラインをめぐって】大腸癌血行性転移の治療　肝・肺転移. 大腸癌Frontier. 1(1): 34-38, 2008.金光幸秀:肝転移補助化学療法後の補助化学療法.ガイドラインサポートハンドブック 大腸癌.杉原健一 編. 医薬ジャーナル社. 123-127, 2009.
      清水泰博、安井健三、佐野力、他:大腸癌同時性肝転移の治療成績 待機肝切除は妥当か？. 消化器内科. 50(1): 80-85, 2010.
      加藤知行、安井久晃、島田安博、他:【最新の大腸癌補助化学療法】大腸癌肝転移切除成績の現状－切除可能肝転移に対する術後補助化学療法. 大腸癌Frontier. 3(1): 40-46, 2010.
      金光幸秀、加藤知行、小森康司、他:【大腸癌肝転移に対する治療のUpdate】大腸癌取扱い規約(第7版)で一新した肝転移分類(H分類とGrade分類). 外科治療. 102(6): 821-828, 2010.
      金光 幸秀、 小森 康司、 木村 賢哉、他:Lower G.I./Colon and Rectum Cancer大腸癌　切除可能な大腸癌肝転移に対する治療方針　術後化学療法の立場から. 癌と化学療法. 39(11):1632-1641, 2012.
      加藤知行、金光幸秀、小森康司:大腸癌肝転移の治療戦略－大腸癌肝転移治療の変遷. 消化器外科．35(9): 1355-1366, 2012.
      金光 幸秀、 志田 大、 塚本 俊輔:【大腸癌肝転移;Consensus & Controversy】 局所治療と薬物療法の組み合わせ　肝切除後の補助療法. 肝・胆・膵. 67(4):529-543, 2013.
      金光 幸秀、 志田 大、 塚本 俊輔:【癌の補助療法アップデート】 大腸癌切除可能肝転移に対する周術期化学療法. 臨床外科. 69(6):690-699, 2014.
      金光 幸秀、 志田 大、 塚本 俊輔、他:【StageIV大腸癌に対する外科的治療戦略】 StageIV大腸癌根治的切除例の予後. 外科. 77(1), 2015.
      金光 幸秀、 志田 大、 塚本 俊輔、他:【大腸癌update-基礎と臨床の研究動向-】 大腸癌治療の進歩と動向　切除可能大腸癌肝転移に対する周術期化学療法. 74(11), 1863-1871, 2016.
      JCOG1006
      平井孝、金光幸秀、小森康司:手術手技　結腸右半切除D3郭清　no touch isolationと支配動脈走行variationへの対応. 手術. 64(7): 1169-1175, 2010.
      Y Takii, S Maruyama, H Nogami: Can the prognosis of colorectal cancer be improved by surgery?. Wold J Gastrointest Surg. 8(8): 574-577. 2016.
      JCOG1007
      金光幸秀:切除不能な遠隔転移例における原発巣切除.ガイドラインサポートハンドブック 大腸癌.杉原健一　編.? 医薬ジャーナル社. 82-85, 2009.
      金光 幸秀、 志田 大、 塚本 俊輔、他:【大腸癌の治療　2016〜2018】 Stage IVにおける原発巣切除のタイミング. 14(4): 210-214, 2016.
      JCOG1018
      長島文夫、北村浩、高須充子、他:がん診療における総合的機能評価.腫瘍内科.9(6):734-742,2012.
      濱口哲弥:高齢者大腸がんに対する薬物療法. 腫瘍内科. 8(3): 222-229, 2011.
  2. 主な学会発表
    1. 委員会承認の治療研究
      JCOG0205
      島田安博、濱口哲弥、森谷冝皓、他:JCOG0205 Stage III治癒切除大腸がんに対する術後補助療法のランダム化第Ⅲ相比較臨床試験:5FU/l-LV対UFT/LV. 第60回日本大腸肛門病学会総会. 2005年10月.
      濱口哲弥、島田安博、斎藤典男、他:JCOG0205　Stage III治癒切除大腸がんに対する術後補助療法のランダム化第III相比較臨床試験)UFT/LVの補助療法としての臨床評価. 第44回日本癌治療学会総会. 2006年10月.
      植竹宏之、石川敏昭、石黒めぐみ、他:わが国における大腸癌術後補助化学療法の大規模比較臨床試験－JCOG0205　MF－. 第37回日本外科系連合学会学術集会. 2012年6月.
      Y Shimada, T Hamaguchi, Y Moriya, et al.: Randomized phase III study of adjuvant chemotherapy with oral uracil and tegafur plus leucovorin versus intravenous fluorouracil and levofolinate in patients (pts) with stage III colon cancer (CC): Final results of Japan clinical oncology group study (JCOG0205). 48th Annual Meeting of the American Society of Clinical Oncology. J Clin Oncol 30 (suppl; abstr 3524), Jun 2012.
      Y Shimada, T Hamaguchi, Y Moriya, et al.: Randomized phase III study of adjuvant chemotherapy with oral uracil and tegafur plus leucovorin versus intravenous fluorouracil and levofolinate in patients (pts) with stage III colon cancer (CC): Final results of Japan Clinical Oncology Group study (JCOG0205). 48th Annual Meeting of the American Society of Clinical Oncology. Jun 2012.
      金光幸秀、島田安博、中村健一、他:臨床病期III期大腸癌に対する術後補助化学療法の第III相試験(JCOG0205）. 第50回日本癌治療学会学術集会. 2012年10月.
      JCOG0212
      S Fujita, S Saito, Y Moriya, et al.: Morbidity and mortality Results from a Prospective Randomized Trial Comparing Mesorectal Excision (ME) and ME with Lateral Lymph Node Dissection for Stage II, III Lower Rectal Cancer. Japan Clinical Oncology Group Study 0212 (NCT00190541). 47th Annual Meeting of the American Society of Clinical Oncology. Jun 2011.
      A Kobayashi, S Fujita, JMizusawa, et al.: Urinary dysfunction after mesorectal excision with and without lateral lymph node dissection for clinical stage II or stage III lower rectal cancer (JCOG0212). 38th Annual Meeting of the European Society of Medical Oncology. Sep 2013.
      S Saito, S Fujita, J Mizusawa, et al.: Sexual dysfunction after rectal cancer surgery: The results from a prospective randomized trial comparing mesorectal excision with and without lateral lymph node dissection for clinical stage II or stage III lower rectal cancer:Japan Clinical Oncology Group Study JCOG0212. 38th Annual Meeting of the European Society of Medical Oncology. Sep 2013.
      S Fujita, J Mizusawa, Y Kanemitsu, et al.: A randomized trial comparing mesorectal excision with or without lateral lymph node dissection for clinical stage II, III lower rectal cancer: Primary endpoint analysis of Japan Clinical Oncology Group Study JCOG0212. 52th Annual Meeting of the American Society of Clinical Oncology. Jun 2016.
      JCOG0404
      S Yamamoto, M Inomata, S Kitano, et al.: Short-term clinical outcomes from a randomized controlled trial to evaluate laparoscopic and open surgery for stage Ⅱ-Ⅲ colorectal cancer: Japan Clinical Oncology Group study JCOG 0404. 2012 Gastrointestinal Cancers Symposium. Jan 2012.
      Y Nishizawa, M Inomata, et al.: Short-term clinical outcomes from a randomized controlled trial to evaluate laparoscopic versus open complete mesocolic excision for stage Ⅱ,Ⅲ colorectal cancer (CRC): Japan Clinical Oncology Group study JCOG 0404. 48th Annual Meeting of the American Society of Clinical Oncology. Jun 2012.
      絹笠祐介、猪股雅史、北野正剛、他:進行大腸癌に対する腹腔鏡下手術と開腹手術とのランダム化比較試験(JCOG0404）;短期成績の報告. 第50回日本癌治療学会学術集会. 2012年10月.
      長谷川博俊、石井良幸、斉田芳久、他:大腸癌に対する腹腔鏡下 vs 開腹手術のRCTに基づく日本からのエビデンスの発信 - JCOG0404の短期成績 -. 第68回日本消化器外科学会総会. 2013年7月.
      K Nakajima, M Inomata, T Akagi, et al.: Quality control by photograph for evaluation of open(OP) and laparoscopic(LAP) colectomy with D3 resection for stage II/III colorectal cancer: Japan Clinical Oncology Group study JCOG 0404. 2014 ASCO Annual Meeting. May 2014.
      M Inomata, H Katayama, J Mizusawa, st al.: A randomized controlled trial to evaluate laparoscopic versus open complete mesocolic excision (CME) for stage II, III colorectal cancer (CRC): First efficacy results from Japan Clinical Oncology Group Study JCOG0404. Gastrointestinal Cancer Symposium. Jan 2015.
      Y Nishizawa, M Ito, N Saito, et al.: Risk factors for postoperative complications of a randmized clinical trial: Laparoscopic versus open surgery with D3 lymphadenectomy for stage II/III colon cancer(JCOG0404). Gastrointestinal Cancer Symposium. Jan 2015.
      T Akagi, M Inomata, H Katayama, et al.: A randomized controlled trial to evaluate laparoscopic versus open with Japanese D3 dissection for stage II,III colorectal cancer (CRC): First efficacy results from Japan Clinical Oncology Group Study JCOG0404. ASCO 2015. May 2015.
      S Fujii, M Inomata, T Akagi, et al.: Transitional impact of short and long-term outcomes of a randomized controlled trial to evaluate laparoscopic versus open surgery for colorectal cancer from Japan Clinical Oncology Group Study JCOG0404. European Cancer Congress. Sep 2015.
      H Katayama, J Mizusawa, K Nakamura,et al.: Institutional heterogeneity of survival and morbidity in laparoscopic surgery for colorectal cancer: from the data of a randomized controlled trial comparing open and laparoscopic surgery (JCOG0404). European Cancer Congress. Sep 2015.
      T Hanai, J Okuda, T Yatsuoka, et al.: Institutional heterogeneity of survival and morbidity in laparoscopic surgery for colorectal cancer: From the data of a randomized controlled trial comparing open and laparoscopic surgery (JCOG0404). European Cancer Congress. Sep 2015.
      F Konishi, T Akagi, M Inomata, et al.: Efficacy results of a randomized controlled trial to evaluate laparoscopic versus open withJapanese D3 dissection for stage II,III colorectal cancer (CRC):Japan Clinical Oncology Group Study JCOG0404. 第53回日本癌治療学会学術集会. 2015年10月.
      S Saito, M Inomata, H Katayama,et al.: Identification of Patient Subgroup Associated with Unfavorable Long-term Outcome in the Laparoscopic Surgery for Colon Cancer Compared with Open Surgery: Subanalysis of a RCT Comparing Open and Laparoscopic Surgery for Colon Cancer (JCOG0404). SAGES. Mar 2017.
      JCOG0603
      金光幸秀、加藤知行、清水泰博、他:わが国における消化器癌補助療法に関する臨床試験によるエビデンス－大腸癌術後補助療法に関するJCOG studyの概要. 第110回日本外科学会定期学術集会. 2010年4月.
      JCOG0910
      T Hamaguchi, Y Shimada, J Mizusawa, et al.: Randomized phase III study of adjuvant chemotherapy with S-1 versus capecitabine (cape) in patients with stage III colon cancer (CC): Results of Japan Clinical Oncology Group study (JCOG0910). ASCO2015 Poster discussion. May 2015.
      Y Yoshida, K Yamazaki, J Mizusawa, et al.: Predictive factor for toxicities and treatment termination in adjuvant capecitabine therapy for stage III colorectal cancer; based on the data of a randomized trial, JCOG0910. ESMO2015 Poster discussion. Sep 2015.
      K Komori, T Hamaguchi, Y Shimada, et al.: Randomized phase III study of adjuvant chemotherapy with S-1 versus capecitabine in patients with stage III colon cancer: Results of Japan Clinical Oncology Group Study (JCOG0910). 第70回日本大腸肛門病学会学術集会シンポジウム. Nov 2015.
      T Hamaguchi, Y Shimada, J Mizusawa, et al.: Randomized phase III study of adjuvant chemotherapy with S-1 versus capecitabine in patients with stage III colorectal cancer: ESMO. Sep 2017.
      滝口 伸浩、濱口 哲弥、島田 安博、他.:III期大腸癌に対するカペシタビン療法とS-1療法とのランダム化第3相比較試験　追加解析. 第56回日本癌治療学会. 2017年10月.
      JCOG1006
      Y Takii, K Komori, M Shiozawa, et al.: Surgical quality assurance in randomized controlled trial of the conventional technique versus the no-touch isolation technique for primary tumor resection in patients with colorectal cancer: Japan clinical oncology group study JCOG1006. ESSO36 Proffered Paper Session. Sep 2016.
      Y Takii, K Komori, M Shiozawa, et al.: Short-term outcome from a randomized controlled trial of the conventional technique versus the no-touch isolation technique for primary tumor resection in patients with colon cancer: Japan Clinical Oncology Group study JCOG1006. ESMO2017 poster display session. 494P. Sep 2017.
      塩澤学、瀧井康公、小森康司、 他:大腸癌切除における適切な切除手順に関するランダム化比較試験(JCOG1006試験)の短期成績. 第73回日本消化器外科学会総会. デジタルポスター P-147-148. 2018年7月.
      JCOG1018
      濱口哲弥.: 高齢者大腸癌患者に対する臨床試験(JCOG1018試験）を開始してわかりつつあること. 第27回日本サイコオンコロジー学会. 2014年10月.
      長島 文夫、北村 浩、宮島 謙介、他: Unfit populationに対するがん化学療法の現状とエビデンス構築のための臨床試験 高齢者を対象としたがん化学療法と臨床開発(消化器)切除不能大腸がんを対象とした第3相試験(JCOG1018)と高齢者総合的機能評価. 臨床薬理. 2012.
      小川朝生、長島文夫、濱口哲弥:Cancer Specific Geriatric Assessment (CSGA)日本語版の開発. 第77回大腸癌研究会. 2012年7月.
      小川朝生、長島文夫、濱口哲弥:高齢者総合機能評価法(Cancer Specific Geriatric Assessment）. 第50回日本癌治療学会学術集会. 2012年10月.
      濱口哲弥:治癒困難な高齢大腸癌の方に適した抗がん剤治療法の確立のための研究. ジャパン・キャンサーリサーチ・プロジェクト. 2018年3月.
      JCOG1502C
      Y Honma, M Ueno, Y Kanemitsu, et al.: Randomized phase III study of observation versus adjuvant capecitabine and oxaliplatin in curatively resected small bowel adenocarcinoma: A Japan Clinical Oncology Group study (JCOG1502C). ASCO-GI. Abstract# TPS539. 2018.
      JCOG1609INT
      K Kataoka, C Caballero, L Collette, et al.: EORTC1527/JCOG1609INT: Diffusion-Weighted Magnetic Resonance Imaging (DW-MRI) Assessment of Liver Metastasis to Improve Surgical Planning (DREAM). American Society of Clinical Oncology annual meeting. Abstract# TPS3633. 2017.
      片岡幸三、中村健一、寺田参省、他: Accelerating a global partnership for clinical research in oncology -Learning from the collaboration with EORTC- 第55回日本癌治療学会学術集会. 2017年10月.
      尾嶋仁、岸庸二、女屋博昭、他: EORTC1527/JCOG1609INT: Diffusion-Weighted Magnetic Resonance Imaging (DW-MRI) Assessment of Liver Metastasis to Improve Surgical Planning (DREAM) 第55回日本癌治療学会学術集会. 2017年10月.
    2. グループ代表者管理の治療研究
      JCOG0212
      K Komori, S Fujita, J Mizusawa, et al.: Risk Factors of Lateral Lymph Node Metastasis in the Patients without Clinical Lateral Pelvic Lymph Node Metastasis. The American Society of Colon and Rectal Surgeons. May 2015.
      JCOG0903
      高島淳生、濱口哲弥、伊藤芳紀、他:肛門管扁平上皮癌に対する治療の国内における現状調査. 第45回日本癌治療学会総会. 2007年10月.
    3. 附随研究等
      JCOG0404
      衛藤剛、猪股雅史、北野正剛、他:進行大腸癌に対する腹腔鏡/開腹手術のRCT(JCOG0404):患者説明同意状況. 第50回日本癌治療学会学術集会. 2012年10月.
      JCOG1007
      金光幸秀、平井孝、小森康司、他:切除不能同時性肝転移大腸癌症例に対する原発巣切除の意義. 第68回日本臨床外科学会総会. 2006年11月.
    4. 総説・解説
      JCOG0404
      猪股雅史、北野正剛、他:進行大腸癌に対する腹腔鏡下手術の第Ⅲ相試験. 第24回日本内視鏡外科学会総会. 2011年12月.
      S Yamamoto, M Inomata, et al.: Short-term clinical outcomes from a randomized controlled trial to evaluate laparoscopic and open surgery for stage Ⅱ-Ⅲ colorectal cancer: Japan Clinical Oncology Group study JCOG 0404. The International Surgical Week. Aug 2011.
トップへ戻る